IAS 2018: Collaboration to Improve Outcomes of Patients with IMIDs

IAS cochairs

The 2018 Interdisciplinary Autoimmune Summit (IAS) kicked off at the Westin Waterfront in Boston, MA on Friday April 27. More than 220 dermatologists, rheumatologists, gastroenterologists, immunologists, internists, and other health care professionals gathered to discuss and collaborate on optimal treatment strategies for patients with immune-mediated inflammatory diseases (IMIDs). The speakers shared complex cases on psoriasis, psoriatic arthritis, rheumatoid arthritis, spondyloarthropathies, Crohn disease, and ulcerative colitis. Twenty-two related exhibitor booths allows the attendees a chance to walk around and learn more about companies and services in the inter-related fields as well as network with their colleagues.

Article continues at: https://www.consultant360.com/exclusives/ias-2018-collaboration-improve-outcomes-patients-immune-mediated-diseases